Skip to main content
    X

    XORTX Therapeutics Inc (XRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.42
    -0.14 (-8.97%)

    Market Cap: $3.05M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(9/14)
    Avg Surprise
    -54.17%
    Streak
    6 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 17
    		$-1.05N/AN/ABeat-452.6%
    Mar 26
    Reported May 15
    		$-0.58N/AN/ABeat-205.6%
    Dec 25
    Reported Feb 26
    		$-0.09N/A+94.30%Beat+92.3%
    Sep 25
    Reported Nov 14
    		$-1.02$-1.58+35.44%Beat-404.5%
    Jun 25
    Reported Aug 14
    		$-0.19N/AN/ABeat+94.5%
    Mar 25
    Reported May 15
    		$-0.19$0.00N/ABeat+93.6%
    Dec 24
    Reported Mar 25
    		$-1.17$-2.08+43.75%Beat-84.0%
    Sep 24
    Reported Nov 14
    		$-0.20N/AN/ABeat+69.8%
    Jun 24
    Reported Aug 14
    		$-3.44$-4.61+25.38%Beat+18.7%
    Mar 24
    Reported Apr 2
    		$-2.96$-4.21+29.69%Beat+37.9%
    Dec 23
    Reported Dec 31
    		$-0.64$-0.81+21.96%Beat-218.0%
    Sep 23
    Reported Nov 14
    		$-0.67$-0.19-252.63%Miss-292.3%
    Jun 23
    Reported Aug 14
    		$-4.23N/A+62.40%Beat+63.8%
    Mar 23
    Reported May 15
    		$-4.77N/A+53.91%Beat+62.1%
    Dec 22
    Reported Mar 31
    		$-0.20$-0.27+25.93%Beat+71.3%
    Sep 22
    Reported Nov 10
    		$-0.17$-0.16-3.96%Miss-798.9%
    Jun 22
    Reported Aug 11
    		$-11.67$-11.25-3.73%Miss-5497.1%
    Mar 22
    Reported May 12
    		$-12.60$-9.90-27.27%Miss-457.3%
    Sep 21
    Reported Nov 29
    		$-0.70$-0.07-863.57%Miss-1409.1%
    Jun 21
    Reported Aug 27
    		$-0.02N/AN/ABeat+51.3%
    Mar 21
    Reported May 31
    		$-0.21N/AN/ABeat-4864.3%
    Dec 20
    Reported Dec 31
    		$-2.26N/AN/ABeat-87.6%
    Sep 20
    Reported Nov 30
    		$-0.05N/AN/ABeat+94.5%
    Jun 20
    Reported Aug 31
    		$-0.04N/AN/ABeat+96.0%
    Mar 20
    Reported Apr 29
    		$-0.00N/AN/ABeat+99.6%
    Dec 19
    Reported Dec 31
    		$-1.21N/AN/ABeat-28.6%
    Sep 19
    Reported Sep 30
    		$-0.84N/AN/ABeat-
    Jun 19
    Reported Jun 30
    		$-0.98N/AN/ABeat-
    Mar 19
    Reported Jun 29
    		$-0.97N/AN/ABeat-
    Dec 18
    Reported Mar 30
    		$-0.94N/AN/ABeat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-0.52EV/EBITDAN/A
    Price/FCF-0.28xFCF Yield-357.43%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-99.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.59xQuick Ratio3.59x
    Trading Statistics
    Beta0.58Avg Volume1.89M
    52-Week High$7.0552-Week Low$1.36

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.65
    SMA 20$1.71
    SMA 50$1.97
    SMA 200$2.23
    EMA 10$1.63
    EMA 20$1.72
    EMA 50$1.89
    EMA 200$2.35

    MACD

    Line: -0.12Signal: -0.11Hist: -0.01

    ADX

    ADX: 20.8+DI: 17.6-DI: 22.0

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down84.0
    PSAR$2.31

    Bollinger Bands

    Upper Band$1.98
    Lower Band$1.44
    %B Position3151%(Upper)
    Band Width-0.04

    RSI (14-Day)

    Neutral
    38.0

    Momentum Oscillators

    Stoch %K26.9
    Stoch %D33.8
    Williams %R-91.7
    ROC (10d)-17.9%
    Momentum-0.31
    CCI (20d)-226.7
    MFI (14d)42.1

    Volatility Measures

    ATR (14d)$0.21(15.0%)
    StdDev (20d)0.13
    Hist Vol144.8%(High)

    Volume Flow

    VWAP$1.46
    OBV171.9M
    AD Line5.0B
    CMF (20d)-0.393

    Volume Metrics

    Avg Vol (20d)2.0M
    Vol Ratio0.0x(Low)
    VWMA (20d)$1.65

    Pivot Points

    R3$1.81
    R2$1.76
    R1$1.66
    Pivot Point$1.61
    S1$1.51
    S2$1.46
    S3$1.36

    Advanced Oscillators

    TSI-16.53
    Ultimate Osc36.2
    KST-180.00

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$17,852$25,487$29,562$29,055$28,102$25,406$25,406$26,157$33,036$25,030$33,178$16,251
    Gross Profit$-17,852$-25,487$-29,562$-29,055$-28,102$-25,406$-25,406$-26,157$-33,036$-25,030$-33,178$-16,251
    Operating Expenses$1.69M$823,297$667,404$716,197$889,945$963,456$661,264$874,749$1.49M$1.09M$983,674$1.39M
    R&D$113,932$33,113$55,707$57,011$186,751$276,309$7,763$34,741$67,683$73,643$182,689$569,713
    SG&A$1.56M$621,873$495,109$392,939$465,827$477,795$407,034$546,633$817,912$512,146$484,847$510,109
    Operating Income$-1,690,650$-823,297$-696,967$-716,197$-889,945$-963,456$-661,264$-874,749$-1,493,690$-1,088,616N/A$-1,393,312
    Interest Income$2,686$1,635$3,922$7,201$12,326$18,421$0$29,023$35,952$31,602$0$63,614
    Interest Expense$84$0$0$0$0$0$0$0$0$16,188$0$0
    Income Before Tax$-1,690,734$-808,472$-599,538$-649,469$-717,700$-698,673$122,535$-587,011$170,066$-3,018,936$2.70M$-1,333,366
    Income Tax Expense$0$0$0$0$0$0$0$0$1$1.05M$-3,682,898$455,024
    Net Income$-1,690,734$-808,472$-599,538$-649,469$-717,700$-698,673$122,535$-587,011$170,066$-3,018,936$2.70M$-1,333,366
    EBITDA$-1,672,416$-797,452$-667,852$-686,812$-862,315$-937,471$-635,120$-848,800$-1,460,641$-1,056,484N/A$-1,376,845
    EBIT$-1,690,734$-823,297$-696,967$-716,197$-889,945$-963,456$-661,264$-874,749$-1,493,690$-1,088,616N/A$-1,393,312
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about XRTX

    News

    XORTX outlines Canadian trial plan for XORTX Therapeutics stock

    XORTX Therapeutics (XRTX) has outlined a two-part Canadian gout study for its XRx-026 program, filing an application on October 8, 2026. This regulatory step provides a development milestone...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    XORTX Therapeutics Inc (ANU.SG) Stock Forum & Discussion

    This page provides a forum for discussion regarding XORTX Therapeutics Inc (ANU.SG) stock on Yahoo Finance. It displays real-time stock data, showing a current price of 1.2560 EUR...

    Yahoo! Finance Canada•10/14/26•Bearish

    Gout’s Standard Of Care Doesn’t Work For Everyone – XORTX Therapeutics Is Aiming To Change That With Its Developmental Drug XORLO

    XORTX Therapeutics Inc. is developing XORLO, a new drug to treat gout, targeting the 9 million individuals in the U.S. who cannot tolerate the standard treatment, allopurinol...

    Benzinga•10/14/26•Bullish

    Net income of XORTX Therapeutics, Inc. – HAN:ANU

    This article focuses on the net income of XORTX Therapeutics, Inc. (HAN:ANU), a pharmaceutical company listed on the Hannover Stock Exchange. It appears to be a financial data snippet...

    TradingView•10/12/26•Neutral

    12 Health Care Stocks Moving In Monday's Intraday Session

    This article identifies top movers among healthcare stocks during Monday's intraday session, highlighting both significant gainers and losers. Mobile-health Network saw the largest increase...

    Benzinga•10/12/26•Somewhat-Bullish

    XRTX Valuation and Fair Value

    P/E
    -0.5x
    Forward P/E
    1.0x
    P/FCF
    -0.3x
    P/B
    0.4x
    See GNG's fair value

    XRTX Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -99.2%
    FCF yield
    -357.4%

    XRTX Competitors

    CompanyTicker
    GRI Bio Inc.GRI
    Ridgetech, Inc.RDGT
    Mustang Bio IncMBIO
    Onconetix IncONCO
    Cadrenal Therapeutics, Inc. Common StockCVKD
    Bioatla IncBCAB
    60 Degrees Pharmaceuticals, Inc. Common StockSXTP
    Revelation Biosciences IncREVB

    Sector: Healthcare

    XRTX Bull Case vs Bear Case

    Bull case

    • XRTX beat EPS estimates in 75.0% of its last 8 reported quarters.

    XRTX Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -0.3%

    XRTX Dividend

    Forward yield
    0.0%

    Frequently Asked Questions About XRTX

    Does XRTX pay dividends?

    XORTX Therapeutics Inc (XRTX) has a dividend payment track record. See the XRTX dividend history page for its current payment status, TTM yield, and recorded payments.

    What is XRTX's market cap?

    XORTX Therapeutics Inc (XRTX) has a market capitalization of $3.05M with a current stock price of $1.42.

    Related stocks

    Sector: Healthcare

    All stocks starting with X

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In